Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NewSpring Capital is a private equity firm with over $3.5 billion in assets under management. It invests in lower-middle market companies across five strategies—Growth, Healthcare, Mezzanine, Holdings, and Franchise—with a focus on accelerating growth through capital solutions and strategic support. Its healthcare platform invests in innovative companies that improve healthcare delivery or reduce costs through technology and operational efficiencies[1][2][5][6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NewSpring Capital.